Division of Immunology, Boston Children's Hospital, Boston, MA, United States of America.
Division of Immunology, Boston Children's Hospital, Boston, MA, United States of America.
Clin Immunol. 2020 Jul;216:108459. doi: 10.1016/j.clim.2020.108459. Epub 2020 May 11.
The COVID-19 pandemic is one of the greatest infectious challenges in recent history. Presently, few treatment options exist and the availability of effective vaccines is at least one year away. There is an urgent need to find currently available, effective therapies in the treatment of patients with COVID-19 infection. In this review, we compare and contrast the use of intravenous immunoglobulin and hyperimmune globulin in the treatment of COVID-19 infection.
COVID-19 大流行是近代历史上最严重的传染病挑战之一。目前,治疗方法有限,有效的疫苗至少要一年后才能问世。因此,迫切需要在治疗 COVID-19 感染患者方面找到现有的有效疗法。在这篇综述中,我们比较和对比了静脉注射免疫球蛋白和高免疫球蛋白在 COVID-19 感染治疗中的应用。